Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound glutamine enteric-coated capsules for diarrhea-predominant irritable bowel syndrome (IBS-D)
ChiCTR2000040413Phase 4Not yet recruiting
- Sponsor
- Union Hospital
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Diarrhea-predominant irritable bowel syndrome (IBS-D) comparing Compound glutamine enteric-coated capsule with Placebo (2 arms). Primary endpoint: Effective rate of improvement of abdominal pain and defecation traits after treatment. Planned start Nov 2020; status: not yet recruiting.
02
Drugs
glutamine
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on ChiCTR2000040413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040413.